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Clinics and pathology 
Disease 
Myeloid and lymphoid neoplasms with FGFR1 
abnormalities (previously: 8p11 myeloproliferative 
syndrome) 
Note 
Different disease phenotypes according to the 
FGFR1 partner gene. 
Phenotype/cell stem origin 
Pluripotent haematopoietic stem cell. 
Epidemiology 
Only one case to date, a 63 years old female with 
myeloproliferative/myelodysplastic neoplasm 
(Gervais et al., 2013). 
Clinics 
Splenomegaly, dyspnea, impaired general condition 
at diagnosis. Rapid disease progression despite 
chemotherapy. 
Evolution 
Disease progressed rapidly and the patient died 6 
months after the diagnosis. 
Prognosis 
Undetermined (myeloid and lymphoid neoplasms 
with FGFR1 abnormalities prognosis is currently 
poor). 
Bone marrow (MGG): hypercellularity with granular hyperplasia, dysgranulopoiesis and few eosinophils. 
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R and G-banding showing t(2;8)(q12;p11). 
 
 
Cohybridization of FGFR1 BAC RP11-350N15 (8p11, green) and RANBP2 RP11-84C2 (2q12, red) showing a dual fusion signal. 
 
 
Schematic representation of RANBP2-FGFR1 fusion transcript. 
 
 
Schematic representation of RANBP2, FGFR1 and RANBP2-FGFR1 predicted fusion protein. 










t(2;8)(q12;p11) without additional abnormality. 










Extracellular ligand-binding domain (with the N-
terminus).  
Unique transmembrane domain.  





Implicated in various cancers, inflammatory 
myofibroblastic tumors (with ALK 2p23), JMML 
and AML with RANBP2-ALK fusion (Rottgers et 




Component of the nuclear pore complex, localised at 
its cytoplasmic side. 




5' RANBP2 - 3' FGFR1; fusion of RANPB2 exon 20 
to FGFR1 exon 9. 
Transcript 
Detection of both RANBP2-FGFR1 transcript and 
FGFR1-RANBP2 reciprocal transcript. 
Fusion protein 
Description 
RANBP2 N-terminal (leucine-rich region) - FGFR1 
C-terminal (TK domain). 
Oncogenesis 
Constitutive activation of FGFR1 kinase activity. 
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